Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data

Lower-grade glioma (LGG) is a crucial pathological type of glioma. Prokineticins have not been reported in LGG. Prokineticins as a member of the multifunctional chemokine-like peptide family are divided into two ligands: PROK1 and PROK2. We evaluated the role of PROK1 and PROK2 in LGG using TCGA dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Junqing, Xiang, Ding, Ma, Xinlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283042/
https://www.ncbi.nlm.nih.gov/pubmed/35845958
http://dx.doi.org/10.1155/2022/2309339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283042/
https://www.ncbi.nlm.nih.gov/pubmed/35845958
http://dx.doi.org/10.1155/2022/2309339

Ejemplares similares